Related Experiment Video
Updated: Jan 22, 2026

Feeder-free Derivation of Melanocytes from Human Pluripotent Stem Cells
Published on: March 3, 2016
The Need for Standardization of PRAME Immunohistochemistry in Melanocytic Neoplasms
Calla M Sullivan1,2, Dominick DiMaio3, Scott Lauer3
1Department of Dermatology, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Abstract:
Accurate diagnosis of melanomas is crucial for proper evaluation and treatment. One immunohistochemical stain frequently utilized is PRAME (PReferentially expressed Antigen in MElanoma), a tumor-associated antigen expressed in most melanomas. This study aims to evaluate the reproducibility of PRAME scoring performed by dermatopathologists at an academic tertiary referral medical center. A blinded survey was designed featuring 21 melanocytic neoplasms stained with PRAME and H&E. For each case, five dermatopathologists provided a PRAME score from 0-4+, percent PRAME positivity, values for H-score, and a descriptive interpretation. Absolute agreement across raters was assessed using a Kappa statistic for PRAME score and intraclass correlations (ICCs) for H-score and PRAME percentage. Statistical analysis indicated poor inter-rater reliability for PRAME score (Kappa = 0.16), percent PRAME positivity (ICC = 0.31), and H-score (ICC = 0.40). Reporting language varied among pathologists. Our study demonstrated that the interpretation of PRAME immunohistochemistry lacks reproducibility, especially for challenging lesions. This suggests that a more rigorous, defined, and reproducible scoring method should be investigated for equivocal cases. Future studies may explore the utility of artificial intelligence software in the interpretation of PRAME for borderline lesions to improve reliability and standardize scoring.
Insights
The PRAME immunohistochemistry stain shows poor reproducibility among dermatopathologists for diagnosing melanomas. Further research is needed for a standardized scoring method for PRAME (PReferentially expressed Antigen in MElanoma) interpretation.
Area of Science:
- Dermatopathology
- Oncology
- Immunohistochemistry
Background:
- Accurate melanoma diagnosis is critical for patient outcomes.
- PRAME (PReferentially expressed Antigen in MElanoma) is a key immunohistochemical marker for melanoma.
- Evaluating the reliability of PRAME scoring is essential for clinical practice.
Purpose of the Study:
- To assess the inter-rater reliability of PRAME scoring among dermatopathologists.
- To identify challenges in PRAME interpretation for melanocytic neoplasms.
- To determine the need for improved PRAME scoring methodologies.
Main Methods:
- A blinded survey of 21 melanocytic neoplasms stained with PRAME and H&E.
- Five dermatopathologists provided PRAME scores (0-4+), percent positivity, H-score, and interpretation.
- Statistical analysis using Kappa statistic and intraclass correlations (ICCs) for reliability assessment.
Main Results:
- Poor inter-rater reliability was observed for PRAME score (Kappa = 0.16).
- Low reliability was also found for percent PRAME positivity (ICC = 0.31) and H-score (ICC = 0.40).
- Significant variation in reporting language among pathologists was noted.
Conclusions:
- PRAME immunohistochemistry interpretation currently lacks sufficient reproducibility, particularly for difficult cases.
- A more standardized and rigorous scoring system for PRAME is required.
- Future studies should explore AI for PRAME interpretation to enhance reliability.
Related Concept Videos
Immunocytochemistry and Immunohistochemistry
These...
Standard Enthalpy of Formation
Standard Electrode Potentials
Measurement: Standard Units
Calculating Standard Free Energy Changes
Standard Solutions

